Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib

Authors:	Liying Wang Hongfeng Zhang Jiaxin Zheng Xiaoli Wei Jingwen Du Haibo Lu Qiuying Sun Weiyu Zhou Rui Zhang Yu Han

Affiliation:	1. Department of Oncology, Chaoyang Central Hospital, Chaoyang, Liaoning Province, China;2. Department of Gastric Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China;3. Department of Nephrology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China;4. Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China;5. Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning Province, China

Abstract:

Keywords:	anti‐EGFR monoclonal antibodies (mAbs) EGFR gastric cancer HER2 RNA interference tyrosine kinase inhibitors (TKIs)